1-8 of 8
Michael B. Jordan
Close
Sort by
Journal Articles

Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab

Clinical Trials & Observations
Shanmuganathan Chandrakasan, Michael B. Jordan, Ashley Baker, Edward M. Behrens, Deepika Bhatla, May Chien, Olive S. Eckstein, Michael M. Henry, Michelle L. Hermiston, Ashley P. Hinson, Jennifer W. Leiding, Abiola Oladapo, Sachit A. Patel, Priti Pednekar, Anish K. Ray, Blachy Dávila Saldaña, Susmita N. Sarangi, Kelly J. Walkovich, John D. Yee, Adi Zoref-Lorenz, Carl E. Allen
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2248–2258.
https://doi.org/10.1182/bloodadvances.2023012217
Published: 2024
Includes: Supplemental data
Journal Articles

Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Bethany Verkamp, Adi Zoref-Lorenz, Brenton Francisco, Pearce Kieser, Joana Mack, Tucker Blackledge, Dafna Brik Simon, Joanne Yacobovich, Michael B. Jordan
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7258–7269.
https://doi.org/10.1182/bloodadvances.2023010546
Published: 2023
Includes: Supplemental data
Journal Articles

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

Ashley V. Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, James A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S. Kean, K. Scott Baker, Lauri M. Burroughs, Jeffrey R. Andolina, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Julie-An Talano, Kirk R. Schultz, Elizabeth O. Stenger, Howard Lin, Adi Zoref-Lorenz, Kenneth L. McClain, Michael B. Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3725–3734.
https://doi.org/10.1182/bloodadvances.2022009478
Published: 2023
Includes: Supplemental data
Journal Articles

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

Clinical Trials & Observations
Blachy J. Dávila Saldaña, Tami John, Challice Bonifant, David Buchbinder, Sharat Chandra, Shanmuganathan Chandrakasan, Weni Chang, Leon Chen, Hannah L. Elfassy, Ashley V. Geerlinks, Roger H. Giller, Rakesh Goyal, David Hagin, Shahidul Islam, Kanwaldeep Mallhi, Holly K. Miller, William Owen, Martha Pacheco, Niraj C. Patel, Christiane Querfeld, Troy Quigg, Nameeta Richard, Deborah Schiff, Evan Shereck, Elizabeth Stenger, Michael B. Jordan, Helen E. Heslop, Catherine M. Bollard, Jeffrey I. Cohen
Journal: Blood Advances
Blood Adv (2022) 6 (2): 452–459.
https://doi.org/10.1182/bloodadvances.2021005291
Published: 2022
Includes: Supplemental data
Journal Articles

IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS

Howard Lin, Brooks P. Scull, Baruch R. Goldberg, Harshal A. Abhyankar, Olive E. Eckstein, Daniel J. Zinn, Joseph Lubega, Jennifer Agrusa, Nader El Mallawaney, Nitya Gulati, Lisa Forbes, Ivan Chinn, Rikhia Chakraborty, Jessica Velasquez, Jordana Goldman, Dalia Bashir, Fong Lam, Eyal Muscal, Michael. M. Henry, Jay N. Greenberg, Stephan Ladisch, Michelle L. Hermiston, Lauren K. Meyer, Michael Jeng, Ahmed Naqvi, Kenneth McClain, Trung Nguyen, Hector Wong, Tsz-Kwong Man, Michael B. Jordan, Carl E. Allen
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3457–3467.
https://doi.org/10.1182/bloodadvances.2021004287
Published: 2021
Includes: Supplemental data
Journal Articles

Possible roads to improve hemophagocytic lymphohistiocytosis outcome

Clinical Trials & Observations
Pietro Merli, Michael B. Jordan, Franco Locatelli
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6127–6129.
https://doi.org/10.1182/bloodadvances.2020003263
Published: 2020
Journal Articles

Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections

Clinical Trials & Observations
Dana T. Lounder, Qiong Bin, Cristina de Min, Michael B. Jordan
Journal: Blood Advances
Blood Adv (2019) 3 (1): 47–50.
https://doi.org/10.1182/bloodadvances.2018025858
Published: 2019
Journal Articles

Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH

Clinical Trials & Observations
Anna Hayden, Molly Lin, Sujin Park, Morris Pudek, Marion Schneider, Michael B. Jordan, Andre Mattman, Luke Y. C. Chen
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2529–2534.
https://doi.org/10.1182/bloodadvances.2017012310
Published: 2017
Includes: Supplemental data